Clinical Trial Update: Traumatic Brain Injury and Effects of Acute Cyclosporine A [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating acute cyclosporine A for traumatic brain injury has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Cyclosporine A (cyclosporine)

Snippet

Sponsor: Edward Hall,PhD | Conditions: Traumatic Brain Injury | Phase 1, Phase 2 | Status: WITHDRAWN